Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiofrequency Catheter Ablation for Atrial Fibrillation Patients on Hemodialysis (From the Kansai Plus Atrial Fibrillation Registry)　- Clinical Impact of Early Recurrence.
Onishi N, Kaitani K, Nakagawa Y, Kobori A, Inoue K, Kurotobi T, Morishima I, Matsui Y, Yamaji H, Nakazawa Y, Kusano K, Shimizu Y, Hanazawa K, Tamura T, Izumi C, Morimoto T, Ono K, Kimura T, Shizuta S; KPAF Investigators. Onishi N, et al. Among authors: yamaji h. Circ J. 2024 Jun 25;88(7):1057-1064. doi: 10.1253/circj.CJ-23-0671. Epub 2024 Jan 11. Circ J. 2024. PMID: 38199253 Free article.
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T. Hirohata A, et al. Among authors: yamaji h. J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062. J Am Coll Cardiol. 2010. PMID: 20202514 Free article. Clinical Trial.
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K. Okishige K, et al. Among authors: yamaji h. J Thromb Thrombolysis. 2019 May;47(4):487-494. doi: 10.1007/s11239-019-01835-8. J Thromb Thrombolysis. 2019. PMID: 30955142 Clinical Trial.
Sex differences in atrial fibrillation ablation outcomes: insights from a large-scale multicentre registry.
Tanaka N, Inoue K, Kobori A, Kaitani K, Morimoto T, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Okada M, Tanaka K, Hirao Y, Oka T, Koyama Y, Okamura A, Iwakura K, Fujii K, Kimura T, Shizuta S. Tanaka N, et al. Among authors: yamaji h. Europace. 2020 Sep 1;22(9):1345-1357. doi: 10.1093/europace/euaa104. Europace. 2020. PMID: 32548641
Long-term efficacy and safety of anticoagulation after atrial fibrillation ablation: data from the JACRE registry.
Inoue K, Hirao K, Kumagai K, Kimura M, Miyauchi Y, Tsushima E, Ohishi M, Kimura K, Yasaka M, Yamaji H, Okawa K, Fujimoto M, Morishima I, Mine T, Shimizu W, Ohe M, Okumura K; JACRE Investigators. Inoue K, et al. Among authors: yamaji h. J Cardiol. 2021 Mar;77(3):263-270. doi: 10.1016/j.jjcc.2020.09.001. Epub 2020 Oct 1. J Cardiol. 2021. PMID: 33011056 Free article.
Real-World Safety Profile of Atrial Fibrillation Ablation Using a Second-Generation Cryoballoon in Japan: Insight From a Large Multicenter Observational Study.
Miyazaki S, Kobori A, Sasaki Y, Miyamoto K, Sato E, Hanazawa K, Morishima I, Kanzaki Y, Yamaji H, Yamao K, Kondo Y, Watanuki M, Kaneshiro T, Uchiyama T, Nakamura K, Hiramatsu S, Nakajima J, Arimoto T, Kaneko S, Osai N, Takagi T, Kaseno K, Takahashi A, Naito S, Kobayashi Y, Hachiya H, Kusano K, Yagi T, Iesaka Y, Tada H. Miyazaki S, et al. Among authors: yamaji h. JACC Clin Electrophysiol. 2021 May;7(5):604-613. doi: 10.1016/j.jacep.2020.11.016. Epub 2021 Feb 24. JACC Clin Electrophysiol. 2021. PMID: 33640351 Free article.
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction.
Fujimoto H, Doi N, Okayama S, Naito M, Kobori A, Kaitani K, Inoue K, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Hirai K, Nakai T, Suzuki M, Yano H, Sakai S, Kimura T, Shizuta S, Saito Y; KPAF investigators. Fujimoto H, et al. Among authors: yamaji h. Europace. 2022 Apr 5;24(4):576-586. doi: 10.1093/europace/euab201. Europace. 2022. PMID: 34463733
Catheter Ablation for Paroxysmal Atrial Fibrillation With Sick Sinus Syndrome: Insights From the Kansai Plus Atrial Fibrillation Registry.
Morishima I, Kanzaki Y, Morita Y, Inoue K, Kobori A, Kaitani K, Kurotobi T, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Tomomatsu T, Ikai Y, Furui K, Yamauchi R, Miyazawa H, Tanaka N, Morimoto T, Kimura T, Shizuta S; KPAF Registry investigators. Morishima I, et al. Among authors: yamaji h. Heart Lung Circ. 2023 Feb;32(2):205-214. doi: 10.1016/j.hlc.2022.09.007. Epub 2022 Oct 20. Heart Lung Circ. 2023. PMID: 36274004
Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry).
Tanaka N, Inoue K, Kobori A, Kaitani K, Morimoto T, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Tanaka K, Hirao Y, Okada M, Koyama Y, Okamura A, Iwakura K, Fujii K, Kimura T, Shizuta S; KPAF investigators. Tanaka N, et al. Among authors: yamaji h. Am J Cardiol. 2023 Feb 15;189:108-118. doi: 10.1016/j.amjcard.2022.11.038. Epub 2022 Dec 14. Am J Cardiol. 2023. PMID: 36525835
133 results